tiprankstipranks
Kinnate Biopharma (KNTE)
NASDAQ:KNTE
Holding KNTE?
Track your performance easily

Kinnate Biopharma (KNTE) Financial Statements

232 Followers

Kinnate Biopharma Financial Overview

Kinnate Biopharma's market cap is currently ―. The company's EPS TTM is $-2.424; its P/E ratio is -1.09; Kinnate Biopharma is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -17.09M$ -30.73M$ -31.92M$ -34.65M$ -32.73M
EBITDA$ -18.08M-$ -32.86M$ -35.19M$ -32.84M
Net Income Common Stockholders$ -17.06M$ -30.73M$ -31.92M$ -32.94M$ -31.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 154.03M$ 167.58M$ 184.70M$ 200.98M$ 227.20M
Total Assets$ 173.60M$ 190.71M$ 216.18M$ 243.88M$ 278.83M
Total Debt$ 3.17M$ 3.38M$ 3.70M$ 3.95M$ 4.18M
Net Debt$ -150.86M$ -164.19M$ -181.00M$ -197.03M$ -223.02M
Total Liabilities$ 14.28M$ 18.29M$ 18.52M$ 21.12M$ 20.36M
Stockholders Equity$ 159.33M$ 172.42M$ 197.64M$ 222.76M$ 223.47M
Cash Flow-
Free Cash Flow$ -17.36M-$ -29.41M$ -27.73M$ -23.84M
Operating Cash Flow$ -17.36M$ -25.54M$ -29.42M$ -27.72M$ -23.75M
Investing Cash Flow$ 22.70M$ 42.63M$ -10.88M$ 55.42M$ 17.57M
Financing Cash Flow-$ 57.00K$ 1.25M$ -9.12M$ 193.00K
Currency in USD

Kinnate Biopharma Earnings and Revenue History

Kinnate Biopharma Debt to Assets

Kinnate Biopharma Cash Flow

Kinnate Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis